BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2030471)

  • 1. OK-432 therapy for unresectable lymphangiomas in children.
    Ogita S; Tsuto T; Deguchi E; Tokiwa K; Nagashima M; Iwai N
    J Pediatr Surg; 1991 Mar; 26(3):263-8; discussion 268-70. PubMed ID: 2030471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OK-432 therapy of lymphangiomas in children.
    Schmidt B; Schimpl G; Höllwarth ME
    Eur J Pediatr; 1996 Aug; 155(8):649-52. PubMed ID: 8839717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OK-432 therapy in 64 patients with lymphangioma.
    Ogita S; Tsuto T; Nakamura K; Deguchi E; Iwai N
    J Pediatr Surg; 1994 Jun; 29(6):784-5. PubMed ID: 8078021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil).
    Brewis C; Pracy JP; Albert DM
    Clin Otolaryngol Allied Sci; 2000 Apr; 25(2):130-4. PubMed ID: 10816217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OK-432 (Picibanil) therapy for lymphangiomas in children.
    Laranne J; Keski-Nisula L; Rautio R; Rautiainen M; Airaksinen M
    Eur Arch Otorhinolaryngol; 2002 May; 259(5):274-8. PubMed ID: 12107533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [OK-432 therapy for lymphangioma in children].
    Ruiz E; Valera ET; Veríssimo F; Tone LG
    J Pediatr (Rio J); 2004; 80(2):154-8. PubMed ID: 15079187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosing of recurrent lymphangioma using OK-432.
    Mikhail M; Kennedy R; Cramer B; Smith T
    J Pediatr Surg; 1995 Aug; 30(8):1159-60. PubMed ID: 7472972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
    Giguère CM; Bauman NM; Sato Y; Burke DK; Greinwald JH; Pransky S; Kelley P; Georgeson K; Smith RJ
    Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1137-44. PubMed ID: 12365884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children?
    Hall N; Ade-Ajayi N; Brewis C; Roebuck DJ; Kiely EM; Drake DP; Spitz L; Pierro A
    Surgery; 2003 Mar; 133(3):238-42. PubMed ID: 12660633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of lymphangiomas arising around cervico-facial region: surgery, bleomycin therapy and OK-432 therapy].
    Ogita S; Tsuto T; Deguchi E; Tokiwa K; Yanagihara J; Iwai N
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1389-91. PubMed ID: 2479816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of lymphangioma with OK432 in children].
    Makowski A; Apanasiewicz A; Chilarski A
    Otolaryngol Pol; 2005; 59(5):723-9. PubMed ID: 16471191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OK-432 therapy for cervical lymphangioma.
    Sichel JY; Udassin R; Gozal D; Koplewitz BZ; Dano I; Eliashar R
    Laryngoscope; 2004 Oct; 114(10):1805-9. PubMed ID: 15454776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lymphangiomas with OK-432 (Picibanil).
    Rautio R; Keski-Nisula L; Laranne J; Laasonen E
    Cardiovasc Intervent Radiol; 2003; 26(1):31-6. PubMed ID: 12491020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children.
    Ogita S; Tsuto T; Tokiwa K; Takahashi T
    Br J Surg; 1987 Aug; 74(8):690-1. PubMed ID: 3651773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerosing treatment of lymphangiomas with OK-432.
    Luzzatto C; Midrio P; Tchaprassian Z; Guglielmi M
    Arch Dis Child; 2000 Apr; 82(4):316-8. PubMed ID: 10735841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional Injection of OK-432 in Cystic Hygroma.
    Hazim M; Moses SS; Tan IP
    Med J Malaysia; 2016 Dec; 71(6):328-330. PubMed ID: 28087956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OK-432 therapy for lymphatic malformation in 32 patients (28 children).
    Claesson G; Kuylenstierna R
    Int J Pediatr Otorhinolaryngol; 2002 Aug; 65(1):1-6. PubMed ID: 12127216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difficulties and risks of surgical treatment of lymphangiomas in the cervicofacial region.
    Ng JW; Wong MK
    J Pediatr Surg; 1996 Oct; 31(10):1463-4. PubMed ID: 8906692
    [No Abstract]   [Full Text] [Related]  

  • 19. OK-432: an effective sclerosing agent for the treatment of lymphangiomas of head and neck.
    Baskota DK; Singh BB; Sinha BK
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):312-7. PubMed ID: 18604046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerotherapy for lymphangioma in children.
    Sanlialp I; Karnak I; Tanyel FC; Senocak ME; Büyükpamukçu N
    Int J Pediatr Otorhinolaryngol; 2003 Jul; 67(7):795-800. PubMed ID: 12791456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.